Related Experiment Videos

Seroepidemiology of the group-A streptococcal carriage state in a private pediatric practice

Insights

Group-A Streptococcus (GAS) is common in well children over one year old, particularly those aged 5-10. Eradicating GAS with erythromycin is often ineffective, with high recurrence rates and sibling transmission observed.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Group-A beta-hemolytic Streptococcus (GAS) is a significant pathogen in pediatric populations.
  • Understanding the epidemiology and carriage of GAS in well children is crucial for infection control.

Purpose of the Study:

  • To determine the incidence of GAS pharyngeal carriage in a cohort of well children.
  • To investigate factors associated with GAS carriage and the effectiveness of treatment.

Main Methods:

  • Throat-swab cultures were collected from 1,362 children aged 3 months to 14 years over 24 months.
  • Follow-up cultures and sibling surveillance were performed on a subset of positive cases.
  • Erythromycin estolate treatment was evaluated in children with persistent positive cultures.

Main Results:

  • Overall GAS incidence was 3.3%, rising to 4.4% in children over one year old.
  • Highest incidence occurred in the 5-7 (8.3%) and 8-10 (4.5%) age groups; no carriage was found in infants under 1 year.
  • Erythromycin treatment showed limited efficacy, with 5 of 19 children remaining culture-positive post-treatment. Eleven percent of siblings were also colonized.

Conclusions:

  • GAS pharyngeal carriage is prevalent in school-aged children.
  • Standard erythromycin treatment appears insufficient for eradicating GAS carriage, suggesting potential for reinfection or persistent carriage.
  • Household transmission among siblings is a notable factor in GAS epidemiology.

Related Concept Videos